Literature DB >> 19826924

In vitro susceptibility to selected antibiotics in bacteria of the Bacteroides fragilis group.

D Chmelar1.   

Abstract

Susceptibility of strains of Bacteroides fragilis group (1284 isolates from cancerous and noncancerous patients in 1994-2004) showed an increase in resistance toward some antibiotics (by 9 % toward penicillin and 8 % toward clindamycin) compared with the resistance level of 10 years ago. The increase in resistance was not detected in the case of ampicillin + sulbactam and metronidazole.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19826924     DOI： 10.1007/s12223-009-0050-5

Source DB:  PubMed          Journal:  Folia Microbiol (Praha)        ISSN： 0015-5632            Impact factor:   2.099


  17 in total

1.  Antibiotic sensitivity of the Bacteroides fragilis group in Europe. European Study Group.

Authors:  I Phillips; A King; C E Nord; B Hoffstedt
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-04       Impact factor: 3.267

2.  Prevalence and characteristics of nim genes encoding 5-nitroimidazole resistance among Bacteroides strains isolated in Morocco.

Authors:  A Haggoud; R A M'Hand; G Reysset; N El M'Daghri; M Benbachir; M Moumni
Journal:  Microb Drug Resist       Date:  2001       Impact factor: 3.431

3.  Clinical resistance to erythromycin and clindamycin in cutaneous propionibacteria isolated from acne patients is associated with mutations in 23S rRNA.

Authors:  J I Ross; E A Eady; J H Cove; C E Jones; A H Ratyal; Y W Miller; S Vyakrnam; W J Cunliffe
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

4.  Multicenter study of in vitro susceptibility of the Bacteroides fragilis group, 1995 to 1996, with comparison of resistance trends from 1990 to 1996.

Authors:  D R Snydman; N V Jacobus; L A McDermott; S Supran; G J Cuchural; S Finegold; L Harrell; D W Hecht; P Iannini; S Jenkins; C Pierson; J Rihs; S L Gorbach
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

5.  Antibiotic resistant propionibacteria in acne: need for policies to modify antibiotic usage.

Authors:  E A Eady; C E Jones; J L Tipper; J H Cove; W J Cunliffe; A M Layton
Journal:  BMJ       Date:  1993-02-27

6.  Multicenter survey of the changing in vitro antimicrobial susceptibilities of clinical isolates of Bacteroides fragilis group, Prevotella, Fusobacterium, Porphyromonas, and Peptostreptococcus species.

Authors:  K E Aldridge; D Ashcraft; K Cambre; C L Pierson; S G Jenkins; J E Rosenblatt
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

7.  Analysis of trends in antimicrobial resistance patterns among clinical isolates of Bacteroides fragilis group species from 1990 to 1994.

Authors:  D R Snydman; L McDermott; G J Cuchural; D W Hecht; P B Iannini; L J Harrell; S G Jenkins; J P O'Keefe; C L Pierson; J D Rihs; V L Yu; S M Finegold; S L Gorbach
Journal:  Clin Infect Dis       Date:  1996-12       Impact factor: 9.079

8.  Metronidazole in prevention and treatment of bacteroides infections after appendicectomy.

Authors:  A T Willis; I R Ferguson; P H Jones; K D Phillips; P V Tearle; R B Berry; R V Fiddian; D F Graham; D H Harland; D B Innes; W M Mee; R L Rothwell-Jackson; I Sutch; C Kilbey; D Edwards
Journal:  Br Med J       Date:  1976-02-07

9.  Insertion of a novel DNA sequence, 1S1186, upstream of the silent carbapenemase gene cfiA, promotes expression of carbapenem resistance in clinical isolates of Bacteroides fragilis.

Authors:  I Podglajen; J Breuil; E Collatz
Journal:  Mol Microbiol       Date:  1994-04       Impact factor: 3.501

10.  Transferable 5-nitroimidazole resistance in the Bacteroides fragilis group.

Authors:  J Breuil; A Dublanchet; N Truffaut; M Sebald
Journal:  Plasmid       Date:  1989-03       Impact factor: 3.466
View more
  1 in total

1.  Oxygen tolerance in anaerobic pathogenic bacteria.

Authors:  Ondřej Holý; Dittmar Chmelař
Journal:  Folia Microbiol (Praha)       Date:  2012-05-10       Impact factor: 2.099
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.